Stock Recommendations: Best Moneycontrol tips For Short Term Stocks

on

Best Stocks For Short Term


17 July 2020, Friday

Today market cross 200 day moving average. Market cross 10900 level after March-2020. Bank Nifty shows tremendous move. Some stocks are doing exceptionally well. Pharma stocks are already trading at 52-week high. Cement sector is also doing well. Reliance plays its own unique game. Jio is continuously taking funding. Overall market mood is bullish.

Some stocks are not doing good. Intraday trading is may become less efficient in this volatile time. So you should be stock pecific and your mindset should be short term trading instead of intraday.


Here are some stock for short term. This stocks can give upto 20% in near term.

Mishra Dhatu Nigam | Brokerage: ICICIdirect| Rating: Buy | Target: Rs 260 |Upside: 20 percent.

The company's Q4FY20 performance was impacted by COVID-19 related concerns. Even in FY21, due to COVID-19, there was a disruption in production activity for 45 days. Subsequently, normal production activities resumed from May 20, 2020. The dispatch of finished materials had already started in May 2020. Backed by a strong order book position, ICICIdirect expect the company to report healthy performance, going forward.

Pfizer | Brokerage: ICICIdirect | Rating: Buy | Target: Rs 4,740 | Upside: 15 percent.
 
Despite divestiture of certain brands and COVID-19 related challenges in Q4FY20, Pfizer posted a steady growth. The company is following a measured approach with de-focusing and hiving off of tail brands and focusing on core strengths areas such as vaccines, pain management, vitamins, GI and CVS. The vaccines segment especially remains at the core of future growth and new launches. ICICIdirect continues to believe in Pfizer’s strong growth track record in power brands and capability in new launches on a fairly consistent basis.

GAIL India | Brokerage: Geojit | Rating: Buy | Target: Rs 119 | Upside: 12 percent. 

Geojit expects the recovery in oil and gas prices and revival of the economy after the lockdown. The company should also benefit from the potential contribution from new pipelines. The Department of Telecommunication will withdraw the claim of Rs 1.83 lakh crore from GAIL. Given these positive catalysts and current upside potential, broking house upgrades its rating to buy on the stock with a revised target price of Rs 119 based on the sum of the parts (SOTP) valuation methodology.

Equitas Holdings | Brokerage: Emkay | Rating: Buy | Target: Rs 65 | LTP: Rs 58.30 | Upside: 11 percent.


Emkay retained its buy rating with a revised target price of Rs 65 (up from Rs 54), based on 0.7x FY22 ABV, given better deposit traction after a scare across SFBs in Q4, which should help the bank in the long run to protect its margins/RoA. However, asset quality performance and listing its SFB will remain key monitorable in the near term. In its Q1FY21 business update, Equitas has reported healthy deposit (ex-CD) growth of 11% QoQ to Rs 114.7 bn, led by strong traction in Retail TD (17% QoQ) in line with the management’s strategy to focus on granular retail deposits.

Extra tips:


Disclaimer: These are my own views. Take your decisions after doing your research.

Location: India

Comments

Post a Comment